NCT07249905
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07249905
Title Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ModeX Therapeutics, An OPKO Health Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.